Influence of Early Coronal Flaring Upon Postoperative Pain After Root Canal Treatment (flaring)

December 9, 2021 updated by: Heba Elasfouri, Cairo University

Influence of Early Coronal Flaring Upon Postoperative Pain Following Root Canal Treatment. A Randomized Clinical Trial

The aim of this clinical study is to evaluate the influence of early coronal flaring upon postoperative pain following root canal treatment in a single session approach.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

All patients will be treated in a single session approach regardless of the group. All molars will be anesthetized either through infiltration in case of maxillary molars or inferior alveolar nerve block in case of mandibular molars using Octocaine 2% with epinephrine 1: 100,000 (Lidocaine HCl, Novocol Pharmaceutical, Ontario, Canada.). Rubber dam will be applied; and access will be opened using Endo access bur.

Canals will be scouted using manual patency file in a watch winding maneuver. In group A, ProGlider PG (size 16, .02 taper) instrument with a length of 25 mm will be used to the working length, then early coronal flaring will be performed using Gates Glidden drill #3 in a brushing motion away from dangerous zone. In group B no coronal flaring will be performed following minimally invasive approach.

Root canals will be copiously irrigated using 10 ml 2.5% sodium hypochlorite NaOCl (Clorox; Egyptian Company for household bleach, Egypt) delivered using 28 Gauge safety Steri Irrigation Tip (DiaDent Group International, Burnaby, BC, Canada) inserted 3 mm below cementoenamel junction. Working length will be determined using electronic apex locator Root ZX II (J. Morita Mfg. Corp, Kyoto, Japan) and confirmed radiographically using parallel technique with receptor holding device.

Canals will be irrigated again with 10ml 1.5% NaOCl, which will be delivered 2mm coronal to apical canal terminus. Irrigation will be hydro-dynamically agitated with EndoActivator device (Dentsply Maillefer, Baillagues, Switzerland) using yellow tips #15/02 inserted 2mm short of working length for 60 seconds. ProGlider PG (size 16, .02 taper) instrument with a length of 25 mm will be used to the working length. Root canals will be shaped using ProTaper next rotary Ni-Ti files (Dentsply Maillefer, Baillagues, Switzerland) till # X3 (Elnaghy et al. 2014). Each file will be used in one molar. Finally, Root canals will be obturated using cold lateral compaction technique. The molars will be permanently restored using composite resin restoration and will be scheduled for extra coronal restoration.

Study Type

Interventional

Enrollment (Anticipated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Cairo, Egypt
        • Cairo University Faculty of Dentistry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 1. Patient age above 18-70 years old.

    • 2. Both males and females will be included.
    • 3. All patients are in a good health without systemic condition.
    • 4. The offending tooth is a molar.
    • 5. The offending molar is indicated for root canal treatment.
    • 6. One molar for every patient.
    • 7. All patients will sign an informed consent.

Exclusion Criteria:

  • 1. Necrotic molars

    • 2. The offending tooth has previous attempt of pulp therapy or root canal treatment.
    • 3. The patient showing any clinical or radiographic evidence of periapical pathosis.
    • 4. Patients received analgesics or systemic antibiotic prior to treatment.
    • 5. Immunocompromised patients.
    • 6. Any unknown infectious disease (e.g. HBV, HCV, HIV, or T.B.)
    • 7. History of cancer with radio or chemotherapy.
    • 8. Offending molar with mobility score ≥2.
    • 9. Offending molar with pocket depth ≥6mm.
    • 10. Immature molars.
    • 11. Nonodontogenic pain.
    • 12. Patients with more than one tooth requiring endodontic intervention

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Early acoronal flaring
In group A, ProGlider PG (size 16, .02 taper) instrument with a length of 25 mm will be used to the working length, then early coronal flaring will be performed using Gates Glidden drill #3 in a brushing motion away from dangerous zone
early coronal flaring will be performed using Gates Glidden drill #3 in a brushing motion away from dangerous zone
Active Comparator: Non coronal flaring
In group B no coronal flaring will be performed following minimally invasive approach.
No coronal flaring will be performed

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
postoperative pain
Time Frame: after 4hours after treatment.
The pain level will be measured using a validated pain scale known as the Verbal Analogue scale
after 4hours after treatment.
postoperative pain
Time Frame: after 6hours after treatment.
The pain level will be measured using a validated pain scale known as the Verbal Analogue scale
after 6hours after treatment.
postoperative pain
Time Frame: after 12hours after treatment.
The pain level will be measured using a validated pain scale known as the Verbal Analogue scale
after 12hours after treatment.
postoperative pain
Time Frame: after 24hours after treatment.
The pain level will be measured using a validated pain scale known as the Verbal Analogue scale
after 24hours after treatment.
postoperative pain
Time Frame: after 48 hours after treatment.
The pain level will be measured using a validated pain scale known as the Verbal Analogue scale
after 48 hours after treatment.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: Heba A ElAsfouri, Cairo University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 1, 2022

Primary Completion (Anticipated)

March 1, 2022

Study Completion (Anticipated)

April 1, 2022

Study Registration Dates

First Submitted

November 28, 2021

First Submitted That Met QC Criteria

December 9, 2021

First Posted (Actual)

December 27, 2021

Study Record Updates

Last Update Posted (Actual)

December 27, 2021

Last Update Submitted That Met QC Criteria

December 9, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • Endo 28-11-2021

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pain

Clinical Trials on coronal flaring

Subscribe